Asymmetry Capital Management, L.P. - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,511,000
-55.6%
62,507
-12.8%
2.71%
-52.4%
Q1 2019$3,405,000
+64.1%
71,675
+24.7%
5.69%
-0.8%
Q4 2018$2,075,000
-53.8%
57,486
-21.2%
5.73%
+38.2%
Q3 2018$4,491,000
+33.6%
72,970
+46.7%
4.15%
+25.6%
Q2 2018$3,361,000
-11.1%
49,756
-28.6%
3.30%
-30.1%
Q1 2018$3,780,000
+56.8%
69,676
+72.8%
4.73%
+44.5%
Q4 2017$2,410,000
+175.7%
40,330
+124.4%
3.27%
+222.6%
Q3 2017$874,000
-34.7%
17,975
-29.4%
1.01%
-36.1%
Q2 2017$1,338,000
-39.5%
25,464
-47.8%
1.59%
-48.6%
Q1 2017$2,213,000
-8.8%
48,800
-23.9%
3.08%
-31.6%
Q4 2016$2,426,000
-57.3%
64,095
-57.5%
4.51%
-54.4%
Q3 2016$5,686,000
+284.4%
150,651
+79.3%
9.89%
+265.0%
Q2 2016$1,479,000
-13.5%
84,026
-40.2%
2.71%
-39.2%
Q1 2016$1,710,000
-18.3%
140,587
+63.7%
4.46%
+40.9%
Q4 2015$2,092,000
+37.4%
85,895
+0.1%
3.16%
-6.8%
Q3 2015$1,523,00085,8343.39%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders